| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.091 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.69 | 0.007 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.39 | 0.008 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |